Issued Patents 2022
Showing 1–6 of 6 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11497749 | Mitoflavoscins: targeting flavin-containing enzymes eliminates cancer stem cells (CSCS) by inhibiting mitochondrial respiration | Michael P. Lisanti | 2022-11-15 |
| 11497759 | Repurposcins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells | Michael P. Lisanti | 2022-11-15 |
| 11441195 | Energetic cancer stem cells (e-CSCs): a new hyper-metabolic and proliferative tumor cell phenotype, driven by mitochondrial energy | Michael P. Lisanti, Marco FIORILLO | 2022-09-13 |
| 11364210 | Mitoriboscins: mitochondrial-based therapeutics targeting cancer cells, bacteria and pathogenic yeast | Michael P. Lisanti | 2022-06-21 |
| 11311501 | Mitoriboscins: mitochondrial-based therapeutics targeting cancer cells, bacteria, and pathogenic yeast | Michael P. Lisanti | 2022-04-26 |
| 11229657 | Targeting hypoxic cancer stem cells (CSCs) with doxycycline: implications for improving anti-angiogenic therapy | Michael P. Lisanti | 2022-01-25 |